Company Press Releases Kathleen Otto 4/25/24 Kathleen Otto 4/25/24 Deloitte Report: Biopharma R&D Trends Show Rebound in Returns Amidst Ongoing Pressures Read More Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Lantern Pharma Launches 'Webinar Wednesdays' Series on Oncology Drug Development Read More Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Form Bio Receives Excellence Award in Cell & Gene Therapy Advancement 2024 Read More Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 EisnerAmper Honored with 2024 Top Workplaces Culture Excellence Awards Read More Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Health Wildcatters' WISH Initiative Emerges Victorious in GAFC 2024 Competition Read More Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Lantern Pharma Expands LP-300 Clinical Trial for Non-Smoking Lung Cancer Patients to Japan and Taiwan Read More Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Johnson & Johnson's Cilta-Cel Receives European Commission Approval for Multiple Myeloma Treatment Read More Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Cost Plus Drugs and Vivid Clear Rx Forge Path to Affordable Medications Read More Kathleen Otto 4/20/24 Kathleen Otto 4/20/24 Advancements in Dengue Fever Treatment: Insights from Island Pharmaceuticals CEO Read More Kathleen Otto 4/19/24 Kathleen Otto 4/19/24 RSM Leaders Recognized in Forbes' Top 200 CPAs Read More Kathleen Otto 4/19/24 Kathleen Otto 4/19/24 EisnerAmper Receives '2024 Best Company to Work for' Award Read More Kathleen Otto 4/19/24 Kathleen Otto 4/19/24 Daniel Powell, Founder of Spark Biomedical, Named Finalist for EY Entrepreneur Of The Year® 2024 Southwest Award Read More Kathleen Otto 4/16/24 Kathleen Otto 4/16/24 Unveiling Good Days' 2024 Chronic Disease Day Campaign Calendar for Health Equity Read More Kathleen Otto 4/16/24 Kathleen Otto 4/16/24 Island Pharmaceuticals' ISLA-101 Shows Promising Pharmacokinetic Data in Dengue Fever Treatment Study Read More Kathleen Otto 4/10/24 Kathleen Otto 4/10/24 Advancements in Cancer Therapy: OncoNano's Breakthrough with muONM-412 Nanoparticles Read More Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Tranexamic Technologies Joins Johnson & Johnson Innovation, JLABS Read More Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Polsinelli Recognized by Patexia for Excellence in Patent Law Read More Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Perkins&Will Launches San Antonio Studio to Meet Southwest Demand Read More Kathleen Otto 4/8/24 Kathleen Otto 4/8/24 DFW Airport's Sustainable Journey: Leading the Way for Environmental Stewardship Read More Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 Lantern Pharma: Revolutionizing Oncology Treatment Development with Speed and Affordability Read More Newer Posts Older Posts
Kathleen Otto 4/25/24 Kathleen Otto 4/25/24 Deloitte Report: Biopharma R&D Trends Show Rebound in Returns Amidst Ongoing Pressures Read More
Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Lantern Pharma Launches 'Webinar Wednesdays' Series on Oncology Drug Development Read More
Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Form Bio Receives Excellence Award in Cell & Gene Therapy Advancement 2024 Read More
Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 EisnerAmper Honored with 2024 Top Workplaces Culture Excellence Awards Read More
Kathleen Otto 4/24/24 Kathleen Otto 4/24/24 Health Wildcatters' WISH Initiative Emerges Victorious in GAFC 2024 Competition Read More
Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Lantern Pharma Expands LP-300 Clinical Trial for Non-Smoking Lung Cancer Patients to Japan and Taiwan Read More
Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Johnson & Johnson's Cilta-Cel Receives European Commission Approval for Multiple Myeloma Treatment Read More
Kathleen Otto 4/22/24 Kathleen Otto 4/22/24 Cost Plus Drugs and Vivid Clear Rx Forge Path to Affordable Medications Read More
Kathleen Otto 4/20/24 Kathleen Otto 4/20/24 Advancements in Dengue Fever Treatment: Insights from Island Pharmaceuticals CEO Read More
Kathleen Otto 4/19/24 Kathleen Otto 4/19/24 EisnerAmper Receives '2024 Best Company to Work for' Award Read More
Kathleen Otto 4/19/24 Kathleen Otto 4/19/24 Daniel Powell, Founder of Spark Biomedical, Named Finalist for EY Entrepreneur Of The Year® 2024 Southwest Award Read More
Kathleen Otto 4/16/24 Kathleen Otto 4/16/24 Unveiling Good Days' 2024 Chronic Disease Day Campaign Calendar for Health Equity Read More
Kathleen Otto 4/16/24 Kathleen Otto 4/16/24 Island Pharmaceuticals' ISLA-101 Shows Promising Pharmacokinetic Data in Dengue Fever Treatment Study Read More
Kathleen Otto 4/10/24 Kathleen Otto 4/10/24 Advancements in Cancer Therapy: OncoNano's Breakthrough with muONM-412 Nanoparticles Read More
Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Tranexamic Technologies Joins Johnson & Johnson Innovation, JLABS Read More
Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Polsinelli Recognized by Patexia for Excellence in Patent Law Read More
Kathleen Otto 4/9/24 Kathleen Otto 4/9/24 Perkins&Will Launches San Antonio Studio to Meet Southwest Demand Read More
Kathleen Otto 4/8/24 Kathleen Otto 4/8/24 DFW Airport's Sustainable Journey: Leading the Way for Environmental Stewardship Read More
Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 Lantern Pharma: Revolutionizing Oncology Treatment Development with Speed and Affordability Read More
